{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:18:58Z","timestamp":1790144338533,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T00:00:00Z","timestamp":1475107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.vaccine.2016.08.018","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T19:35:01Z","timestamp":1473449701000},"page":"5436-5441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories"],"prefix":"10.1016","volume":"34","author":[{"given":"Larisa","family":"Rudenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Yeolekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Kiseleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Isakova-Sivak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.08.018_b0005","unstructured":"WHO. Influenza (Seasonal). Fact sheet N\u00b0211, March 2014. <http:\/\/www.who.int\/mediacentre\/factsheets\/fs211\/en\/>; 2014."},{"key":"10.1016\/j.vaccine.2016.08.018_b0010","unstructured":"WHO. Global pandemic influenza action plan to increase vaccine supply. Geneva, Switzerland. WHO\/IVB\/06.13; WHO\/CDS\/EPR\/GIP\/2006.1. <http:\/\/whqlibdoc.who.int\/hq\/2006\/WHO_IVB_06.13_eng.pdf?ua=1>; 2006."},{"key":"10.1016\/j.vaccine.2016.08.018_b0015","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1016\/j.vaccine.2006.07.021","article-title":"A global pandemic influenza vaccine action plan","volume":"24","author":"Kieny","year":"2006","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2016.08.018_b0020","doi-asserted-by":"crossref","first-page":"A40","DOI":"10.1016\/j.vaccine.2011.04.122","article-title":"Live attenuated pandemic influenza vaccine: clinical studies on A\/17\/California\/2009\/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries","volume":"29","author":"Rudenko","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.018_b0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jviromet.2015.10.009","article-title":"Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses","volume":"227","author":"Shcherbik","year":"2016","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2016.08.018_b0030","doi-asserted-by":"crossref","first-page":"e0138951","DOI":"10.1371\/journal.pone.0138951","article-title":"Generation and characterization of live attenuated influenza A(H7N9) candidate vaccine virus based on russian donor of attenuation","volume":"10","author":"Shcherbik","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2016.08.018_b0035","doi-asserted-by":"crossref","first-page":"e92580","DOI":"10.1371\/journal.pone.0092580","article-title":"Rapid strategy for screening by pyrosequencing of influenza virus reassortants\u2013candidates for live attenuated vaccines","volume":"9","author":"Shcherbik","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2016.08.018_b0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jviromet.2013.09.003","article-title":"Application of real time RT-PCR for the genetic homogeneity and stability tests of the seed candidates for live attenuated influenza vaccine production","volume":"195","author":"Shcherbik","year":"2014","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2016.08.018_b0045","first-page":"208","article-title":"Live attenuated influenza vaccines against highly pathogenic H5N1 avian Influenza: development and preclinical characterization","volume":"4","author":"Larionova","year":"2013","journal-title":"J Vaccines Vaccin"},{"key":"10.1016\/j.vaccine.2016.08.018_b0050","doi-asserted-by":"crossref","first-page":"e102339","DOI":"10.1371\/journal.pone.0102339","article-title":"Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus","volume":"9","author":"Isakova-Sivak","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2016.08.018_b0055","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/mt.2016.23","article-title":"H7N9 Live attenuated influenza vaccine is highly immunogenic, prevents virus replication, and protects against severe bronchopneumonia in ferrets","volume":"24","author":"de Jonge","year":"2016","journal-title":"Mol Ther: J Am Soc Gene Ther"},{"key":"10.1016\/j.vaccine.2016.08.018_b0060","first-page":"31","article-title":"Study of biological properties of cold-adapted reassortant strain of influenza virus subtype H7N3","author":"Desheva Iu","year":"2009","journal-title":"Zhurnal mikrobiologii, epidemiologii, i immunobiologii"},{"key":"10.1016\/j.vaccine.2016.08.018_b0065","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.1016\/j.vaccine.2011.09.049","article-title":"Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets","volume":"29","author":"Stittelaar","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.018_b0070","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/infdis\/jir596","article-title":"Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets","volume":"204","author":"Gustin","year":"2011","journal-title":"J Infectious Diseases"},{"key":"10.1016\/j.vaccine.2016.08.018_b0075","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2174\/1874285801408010154","article-title":"Live attenuated influenza H7N3 vaccine is safe, immunogenic and confers protection in animal models","volume":"8","author":"Rekstin","year":"2014","journal-title":"Open Microbiol J"},{"key":"10.1016\/j.vaccine.2016.08.018_b0080","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.vaccine.2014.11.008","article-title":"Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine","volume":"33","author":"Carter","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.018_b0085","doi-asserted-by":"crossref","first-page":"e87962","DOI":"10.1371\/journal.pone.0087962","article-title":"Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo-controlled, randomized double-blind phase I study of live attenuated H7N3 influenza vaccine","volume":"9","author":"Rudenko","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2016.08.018_b0090","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1080\/21645515.2015.1010859","article-title":"H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers","volume":"11","author":"Isakova-Sivak","year":"2015","journal-title":"Human Vaccines Immunotherapeutics"},{"key":"10.1016\/j.vaccine.2016.08.018_b0095","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1016\/j.vaccine.2015.08.019","article-title":"Clinical testing of pre-pandemic live attenuated A\/H5N2 influenza candidate vaccine in adult volunteers: results from a placebo-controlled, randomized double-blind phase I study","volume":"33","author":"Rudenko","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.018_b0100","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1473-3099(15)00378-3","article-title":"H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial","volume":"16","author":"Rudenko","year":"2016","journal-title":"Lancet Infectious Diseases"},{"key":"10.1016\/j.vaccine.2016.08.018_b0105","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.vaccine.2012.12.082","article-title":"Safety and immune responses following administration of H1N1 live attenuated influenza vaccine in Thais","volume":"31","author":"Phonrat","year":"2013","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2016.08.018_b0110","doi-asserted-by":"crossref","first-page":"A16","DOI":"10.1016\/j.vaccine.2011.04.119","article-title":"A pandemic influenza vaccine in India: from strain to sale within 12months","volume":"29","author":"Dhere","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.018_b0115","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4161\/hv.22317","article-title":"A post-marketing surveillance study of a human live-virus pandemic influenza A (H1N1) vaccine (Nasovac ((R))) in India","volume":"9","author":"Kulkarni","year":"2013","journal-title":"Human Vaccines Immunotherapeutics"},{"key":"10.1016\/j.vaccine.2016.08.018_b0120","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4161\/hv.27490","article-title":"Effectiveness of an Indian-made attenuated influenza A(H1N1)pdm 2009 vaccine: a case control study","volume":"10","author":"Kulkarni","year":"2014","journal-title":"Human Vaccines Immunotherapeutics"},{"key":"10.1016\/j.vaccine.2016.08.018_b0125","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1016\/j.vaccine.2015.04.048","article-title":"Safety of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled clinical trial among children in urban Bangladesh","volume":"33","author":"Ortiz","year":"2015","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16306752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16306752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T06:23:06Z","timestamp":1568355786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16306752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":25,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0264410X16306752"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}